AVROBIO

Biotechnology Research • Cambridge, Massachusetts, United States • 11-20 Employees

Company overview

Headquarters	100 Technology Sq, 6th Floor, Cambridge, Massachusetts 02139, US
Phone number	+13396663320
Websites	avrobio.com tectonictx.com
NAICS	541714
SIC	873
Keywords	Gene Therapy And Rare Disease
Employees	11-20
Socials

Key Contact at AVROBIO

Diana Clarke

Senior Director Of Gene Therapy, Cmc Strategies

AVROBIO Email Formats

AVROBIO uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 42.1% of the time.

Format	Example	Percentage
{first name}.{last name}@company.com	john.doe@company.com	42.1%
{first name}@company.com	john@company.com	25.3%
{first name initial}{last name}@company.com	{first name initial}doe@company.com	14.8%
{first name}{last name}@company.com	johndoe@company.com	10.2%
{last name}@company.com	doe@company.com	7.6%

About AVROBIO

Our vision is to bring personalized gene therapy to the world. We target the root cause of genetic disease by introducing a functional copy of the affected gene into patients’ own hematopoietic stem cells (HSCs), with the goal of durably expressing the therapeutic protein throughout the body, including the central nervous system. Our first-in-class pipeline includes clinical programs for Gaucher disease and Hunter syndrome, as well as a preclinical program for Pompe disease. Our proprietary plato® gene therapy platform is scalable for planned global commercialization. We are headquartered in Cambridge, Mass. For additional information, visit avrobio.com, and follow us on Twitter and LinkedIn.

AVROBIO revenue & valuation

Annual revenue	$1,177,500
Revenue per employee	$70,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$3,800,000
Total funding	$60,000,000